UnknownNot Applicable

Acute Hypertensive Cerebral Hemmorrhage Surgery

China1,000 participantsStarted 2022-01-01

Plain-language summary

The Neuroendoscopic, Trans-occipital Approach Evacuation of Acute Hypertensive Cerebral Hemmorrhage Combined Low-drainage Surgery: a Multi-center Clinical Trial

Who can participate

Age range15 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Diagnosed patients with spontaneous cerebral hemorrhage in the basal ganglia (in line with the diagnostic criteria of the American Adult Spontaneous Cerebral Hemorrhage Treatment Guidelines (2015)).
✓. Head CT showed; hematoma volume ≥ 30ml, intraventricular hemorrhage is not counted as hemorrhage volume.
✓. Time from onset to hospital admission ≤8h.
✓. The age of the patient is 15-75 years old.
✓. Glasgow Coma Score (GCS)\> 5 points.
✓. The patient/family knows and signs the informed consent form.
✓. Have a clear history of hypertension in the past.

Exclusion criteria

✕. Bleeding caused by aneurysm, vascular malformation or tumor stroke.
✕. Combined with a history of head injury or trauma.
✕. There is more blood in the skull.
✕. Past mental disorders or neurological dysfunction.
✕. A history of procoagulant dysfunction or anticoagulant drugs.
✕. Patients with complications such as liver and kidney dysfunction.
✕. Those with poor compliance.
✕. Pregnant patients.

What they're measuring

Clinical remission rate

Timeframe: 1 month postoperation

Trial details

NCT IDNCT04957849

SponsorShanghai Changzheng Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-12-31

Contact for this trial

Lijun Hou, MD,PhD

86 21 81885671 houlijunsmmu@163.com

View on ClinicalTrials.gov More Hypertensive Intracerebral Hemorrhage trials